HLTH Stock Overview
Operates as a healthcare technology company. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Cue Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.091 |
| 52 Week High | US$0.78 |
| 52 Week Low | US$0.078 |
| Beta | 1.3 |
| 1 Month Change | -35.74% |
| 3 Month Change | -64.64% |
| 1 Year Change | -87.13% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.55% |
Recent News & Updates
Recent updates
Take Care Before Jumping Onto Cue Health Inc. (NASDAQ:HLTH) Even Though It's 26% Cheaper
May 10
Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 26%
Mar 22Cue Health Inc.'s (NASDAQ:HLTH) Price Is Right But Growth Is Lacking After Shares Rocket 31%
Jan 28We're A Little Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Rate
Jan 06Investors Don't See Light At End Of Cue Health Inc.'s (NASDAQ:HLTH) Tunnel And Push Stock Down 28%
Nov 10These Analysts Think Cue Health Inc.'s (NASDAQ:HLTH) Sales Are Under Threat
Aug 14Can Cue Health (NASDAQ:HLTH) Afford To Invest In Growth?
Jul 12Revenue Downgrade: Here's What Analysts Forecast For Cue Health Inc. (NASDAQ:HLTH)
May 15Cue Health Inc. (NASDAQ:HLTH) Analysts Just Slashed This Year's Revenue Estimates By 56%
Mar 21We Think Cue Health (NASDAQ:HLTH) Needs To Drive Business Growth Carefully
Mar 12Cue Health Inc.'s (NASDAQ:HLTH) Intrinsic Value Is Potentially 44% Above Its Share Price
Feb 13Cue Health Inc. (NASDAQ:HLTH) Analysts Just Trimmed Their Revenue Forecasts By 24%
Nov 18Here's Why We're Not Too Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Situation
Oct 30Cue Health applies for FDA emergency use nod for its flu & COVID-19 molecular test
Oct 04Cue Health appoints chief medical oficer
Sep 08Shareholder Returns
| HLTH | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -23.2% | -3.4% | -3.5% |
| 1Y | -87.1% | 9.0% | 22.1% |
Return vs Industry: HLTH underperformed the US Medical Equipment industry which returned 5.5% over the past year.
Return vs Market: HLTH underperformed the US Market which returned 25.6% over the past year.
Price Volatility
| HLTH volatility | |
|---|---|
| HLTH Average Weekly Movement | 17.0% |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: HLTH's share price has been volatile over the past 3 months.
Volatility Over Time: HLTH's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 726 | Clint Sever | www.cuehealth.com |
Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories.
Cue Health Inc. Fundamentals Summary
| HLTH fundamental statistics | |
|---|---|
| Market cap | US$14.72m |
| Earnings (TTM) | -US$373.46m |
| Revenue (TTM) | US$70.94m |
0.2x
P/S Ratio0.0x
P/E RatioIs HLTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HLTH income statement (TTM) | |
|---|---|
| Revenue | US$70.94m |
| Cost of Revenue | US$265.71m |
| Gross Profit | -US$194.77m |
| Other Expenses | US$178.69m |
| Earnings | -US$373.46m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.35 |
| Gross Margin | -274.58% |
| Net Profit Margin | -526.48% |
| Debt/Equity Ratio | 0% |
How did HLTH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/05/28 06:22 |
| End of Day Share Price | 2024/05/28 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cue Health Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Mark Massaro | BTIG |
| Matthew Sykes | Goldman Sachs |